Risk of Recurrence in Early-Stage, HER2-Positive Breast Cancer

被引：0
|
作者：
Isaacs, Claudine [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Med & Oncol, Washington, DC 20007 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 08期
关键词：
ADJUVANT CHEMOTHERAPY; TRASTUZUMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 6
页数：4
相关论文
共 50 条
  • [1] Neratinib in Early-Stage HER2-Positive Breast Cancer
    Cherian, Mathew A.
    Ma, Cynthia X.
    [J]. BREAST DISEASES, 2015, 26 (04): : 285 - 287
  • [2] Advances in the Treatment of Early-Stage HER2-Positive Breast Cancer
    Sharifi, Marina
    Wisinski, Kari B.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 482 - 492
  • [3] Systemic therapy for HER2-positive early-stage breast cancer
    Mathew, Aju
    Romond, Edward H.
    [J]. CURRENT PROBLEMS IN CANCER, 2016, 40 (2-4) : 106 - 116
  • [4] Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer
    O'Brien, Diana Roth
    Boe, Lillian
    Montagna, Giacomo
    Mueller, Boris
    Chino, Fumiko
    Cuaron, John
    Choi, J. Isabelle
    Xu, Amy
    Bernstein, Michael
    McCormick, Beryl
    Powell, Simon
    Khan, Atif J.
    Braunstein, Lior Z.
    [J]. International Journal of Radiation Oncology Biology Physics, 2024, 118 (02): : 468 - 473
  • [5] PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
    Elisa Agostinetto
    Lieveke Ameye
    Samuel Martel
    Philippe Aftimos
    Noam Pondé
    Christian Maurer
    Sarra El-Abed
    Yingbo Wang
    Malou Vicente
    Saranya Chumsri
    Judith Bliss
    Judith Kroep
    Marco Colleoni
    Fausto Petrelli
    Lucia Del Mastro
    Alvaro Moreno-Aspitia
    Martine Piccart
    Marianne Paesmans
    Evandro de Azambuja
    Matteo Lambertini
    [J]. npj Breast Cancer, 8
  • [6] Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
    Kourie, Hampig Raphael
    El Rassy, Elie
    Clatot, Florian
    de Azambuja, Evandro
    Lambertini, Matteo
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 3363 - 3372
  • [7] Spotlight on trastuzumab in the management of HER2-positive metastatic and early-stage breast cancer
    Plosker, Greg L.
    Keam, Susan J.
    [J]. BIODRUGS, 2006, 20 (04) : 259 - 262
  • [8] PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
    Agostinetto, Elisa
    Ameye, Lieveke
    Martel, Samuel
    Aftimos, Philippe
    Ponde, Noam
    Maurer, Christian
    El-Abed, Sarra
    Wang, Yingbo
    Vicente, Malou
    Chumsri, Saranya
    Bliss, Judith
    Kroep, Judith
    Colleoni, Marco
    Petrelli, Fausto
    Del Mastro, Lucia
    Moreno-Aspitia, Alvaro
    Piccart, Martine
    Paesmans, Marianne
    de Azambuja, Evandro
    Lambertini, Matteo
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [9] Spotlight on Trastuzumab in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer
    Greg L. Plosker
    Susan J. Keam
    [J]. BioDrugs, 2006, 20 : 259 - 262
  • [10] HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
    Xu, Luying
    Xie, Yuxin
    Gou, Qiheng
    Cai, Rui
    Bao, Rong
    Huang, Yucheng
    Tang, Ruisi
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
12345